Ocular Therapeutix (OCUL) Shares Outstanding: 2013-2025
Historic Shares Outstanding for Ocular Therapeutix (OCUL) over the last 8 years, with Sep 2025 value amounting to $174.9 million.
- Ocular Therapeutix's Shares Outstanding rose 11.68% to $174.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.9 million, marking a year-over-year increase of 11.68%. This contributed to the annual value of $157.7 million for FY2024, which is 37.22% up from last year.
- As of Q3 2025, Ocular Therapeutix's Shares Outstanding stood at $174.9 million, which was up 1.17% from $172.9 million recorded in Q2 2025.
- In the past 5 years, Ocular Therapeutix's Shares Outstanding ranged from a high of $174.9 million in Q3 2025 and a low of $76.2 million during Q1 2021.
- Moreover, its 3-year median value for Shares Outstanding was $155.6 million (2024), whereas its average is $134.8 million.
- Data for Ocular Therapeutix's Shares Outstanding shows a peak YoY spiked of 99.58% (in 2024) over the last 5 years.
- Quarterly analysis of 5 years shows Ocular Therapeutix's Shares Outstanding stood at $76.7 million in 2021, then grew by 0.61% to $77.2 million in 2022, then skyrocketed by 48.91% to $115.0 million in 2023, then soared by 37.22% to $157.7 million in 2024, then increased by 11.68% to $174.9 million in 2025.
- Its Shares Outstanding was $174.9 million in Q3 2025, compared to $172.9 million in Q2 2025 and $159.3 million in Q1 2025.